ResMed (RMD) insider plans Rule 144 sale of 50 common shares

Rhea-AI Filing Summary

ResMed (RMD) received a notice of proposed stock sales under Rule 144 from an insider. The filer plans to sell 50 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $12,087.50. These shares were acquired on 11/11/2023 through restricted stock vesting from the issuer as compensation. The notice also reports that the same person sold 50 shares of common stock on 12/01/2025 for gross proceeds of $12,208.00 over the past three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50	12087.50	145966294	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2023	Restricted Stock Vesting	Issuer			50	11/11/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael J. Rider 9001 Spectrum Center Blvd. San Diego CA 92123	Common	12/01/2025	50	12208.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ResMed (RMD) Form 144 filing disclose?

The filing discloses that an insider has notified the SEC of an intended sale of 50 shares of ResMed common stock under Rule 144, using Fidelity Brokerage Services LLC as broker on the NYSE.

How many ResMed (RMD) shares are proposed to be sold in this Form 144?

The notice covers a proposed sale of 50 shares of common stock with an indicated aggregate market value of $12,087.50.

When were the ResMed (RMD) shares in this Form 144 acquired and how?

The 50 shares were acquired on 11/11/2023 through restricted stock vesting from the issuer as compensation.

What prior ResMed (RMD) stock sales are reported in the last three months?

The person filing the notice reports a prior sale of 50 shares of ResMed common stock on 12/01/2025 for $12,208.00 in gross proceeds.

Which broker and exchange are involved in the planned ResMed (RMD) sale?

The proposed sale is to be executed through Fidelity Brokerage Services LLC on the NYSE, as stated in the filing.

What does the Rule 144 representation in the ResMed (RMD) filing state?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.